Coronavirus will have a ‘big impact’ on one-third of U.S. clinical trial sites, survey finds

Nearly one-third of clinical trial sites expect the novel coronavirus will have a “big or extremely big” impact on their ability to recruit patients for new trials or keep patients already enrolled in existing studies compliant with scheduling, a new survey finds.

In addition, 39% of 170 clinical trial sites surveyed in the U.S.